Filter by
Date
Cancer type
Cancer stage
Biomarker
Method of analysis
Selected categories
June 2024
Targeted Sequencing of Circulating Tumour Cells Captured by Parsortix System Enables Low Frequency Variant Analysis with VarMapTM Pan-Cancer NGS Panel
ANGLE Europe Limited, Guildford, UK, published at the EACR Annual Meeting 2024
June 2024
Detection of DNA damage in circulating tumour cells harvested from blood samples of ovarian and prostate cancer patients
ANGLE Europe Limited, Guildford, UK, published at the EACR Annual Meeting 2024
April 2024
Development and analytical validation of a novel assay for HER2 assessment on circulating tumour cells using Parsortix® isolation and BioView imaging technologies
ANGLE Europe Limited, Guildford, UK, published at the AACR Annual Meeting 2024
March 2024
Integrating isolation using label-independent microfluidics and advanced staining for comprehensive Circulating Tumour Cell Analysis
ANGLE Europe Limited, Guildford, UK, published at the 14th European Breast Cancer Conference March 22 2024
March 2024
Interrogating HER2 status in Circulating Tumor Cells isolated using the Parsortix® System from Metastatic Breast Cancer patients
ANGLE Europe Limited, Guildford, UK, published at the 14th European Breast Cancer Conference March 22 2024
May, 2023
Circulating Tumour Cell Analysis to Evaluate Docetaxel Treatment Response and Resistance Markers in Prostate Cancer – NCRI Cancer Conference abstracts
1
23 ...
9